Constitutional Pericentric Inversion 9 in Korean Patients with Chronic Myelogenous Leukemia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Although the pericentric inversion of chromosome 9, inv(9)(p11q13), is generally considered a normal variation, it is also associated with solid tumors and several hematologic malignancies such as biphenotypic acute leukemia, ALL, AML, and myeloproliferative neoplasms. However, to the best of our knowledge, there have been no reports that suggest an association between CML and constitutional pericentric inversion of chromosome 9. The purpose of this retrospective study was to investigate the frequency and clinical features of CML patients with concomitant inv(9) and t(9;22)(q34;q11.2) variation at our institution. Methods : We reviewed the bone marrow chromosome database entries between October 2006 and December 2008 to identify patients with concomitant inv(9) and t(9;22) variations. Laboratory and clinical data of the patients were obtained from the electronic medical record system. Results : Among the 51 CML patients, 4 (7.8%) had concomitant inv(9) and t(9;22) variations. Conclusions : Although the association between inv(9) variation and CML is still controversial, we believe that hematologists should consider the role of constitutional inv(9) variation in CML patients to avoid overlooking the impaired engraftment potential of hematopoietic stem cells harboring inv(9). Therefore, we suggest that more effort should be invested to develop cytogenetic tests for detecting constitutional inv(9) variation in CML patients. (Korean J Lab Med 2010;30:218-23)
Abstract
Background : Although the pericentric inversion of chromosome 9, inv(9)(p11q13), is generally considered a normal variation, it is also associated with solid tumors and several hematologic malignancies such as biphenotypic acute leukemia, ALL, AML, and myeloproliferative neoplasms. However, to the best of our knowledge, there have been no reports that suggest an association between CML and constitutional pericentric inversion of chromosome 9. The purpose of this retrospective study was to investigate the frequency and clinical features of CML patients with concomitant inv(9) and t(9;22)(q34;q11.2) variation at our institution. Methods : We reviewed the bone marrow chromosome database entries between October 2006 and December 2008 to identify patients with concomitant inv(9) and t(9;22) variations. Laboratory and clinical data of the patients were obtained from the electronic medical record system. Results : Among the 51 CML patients, 4 (7.8%) had concomitant inv(9) and t(9;22) variations. Conclusions : Although the association between inv(9) variation and CML is still controversial, we believe that hematologists should consider the role of constitutional inv(9) variation in CML patients to avoid overlooking the impaired engraftment potential of hematopoietic stem cells harboring inv(9). Therefore, we suggest that more effort should be invested to develop cytogenetic tests for detecting constitutional inv(9) variation in CML patients. (Korean J Lab Med 2010;30:218-23)
참고문헌 (20)
- Keung YK, "Constitutional pericentric inversion of chromosome 9 and acute leukemia", Cancer Genet Cytogenet, 145, pp.82~85 (2003)
- 허정원, "혈액 종양 환자에서 관찰되는 체질성 염색체 이상의 빈도와 종류", The Korean Journal of Laboratory Medicine, 26(1), pp.64~69 (2006), 대한진단검사의학회
- "Mitelman database of chromosome aberrations in cancer"[URL]
- Betz JL, "Tirtorahardjo B, Moore MW, Cotter PD. Acquired inv(9): what is its significance?", Cancer Genet Cytogenet, 160, pp.76~78 (2005)
- Wan TS, "Acquired pericentric inversion of chromosome 9 in essential thrombocythemia", Hum Genet, 106, pp.669~670 (2000)
- Alimena G, "Cytogenetic pattern in leukemic cells of patients with constitutional chromosome anomalies", Cancer Genet Cytogenet, 16, pp.207~218 (1985)
- Benitez J, "Frequency of constitutional chromosome alterations in patients with hematologic neoplasias", Cancer Genet Cytogenet, 24, pp.345~354 (1987)
- Cerretini R, "Evaluation of constitutional chromosome aberrations in hematologic disorders", Cancer Genet Cytogenet, 134, pp.133~137 (2002)
- Welborn J, "Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies", Cancer Genet Cytogenet, 149, pp.137~153 (2004)
- Imashuku S, "Constitutional pericentric inversion of chromosome 9 and haemopoietic stem cell transplantation: delayed engraftment", Br J Haematol, 118, pp.1195~1196 (2002)
- Keung YK, "Constitutional pericentric inversion of chromosome 9 and bone marrow transplantation", Br J Haematol, 123, pp.748~749 (2003)
- Bernstein R, "The incidence, type, and subsequent evolution of 14 variant Ph1 translocations in 180 South African patients with Ph1-positive chronic myeloid leukemia", Cancer Genet Cytogenet, 12, pp.225~238 (1984)
- Lee DS, "A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression", Genes Chromosomes Cancer, 37, pp.291~299 (2003)
- Lim LC, "Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia", Int J Mol Med, 4, pp.665~667 (1999)
- Lo Nigro L, "Association of cytogenetic abnormalities with detection of BCRABL fusion transcripts in children with T-lineage lymphoproliferative diseases (T-ALL and T-NHL)", Pediatr Blood Cancer, 42, pp.278~280 (2004)
- Ohtaki K, "Near-triploid Ph-positive leukemia", Cancer Genet Cytogenet, 18, pp.113~121 (1985)
- Peterson LC, "Acute basophilic leukemia. A clinical, morphologic, and cytogenetic study of eight cases", Am J Clin Pathol, 96, pp.160~170 (1991)
- Lourenco GJ, "Inherited pericentric inversion of chromosome 9 in acquired hematological disorders", Ann Hematol, 86, pp.465~467 (2007)
- Manola KN, "Constitutional pericentric inversion of chromosome 9 and hematopoietic recovery after allogeneic stem cell transplantation", Ann Hematol, 85, pp.611~615 (2006)
- Park TS, "Concomitant t(3;3)(q21;q26), trisomy 19, and E255V mutation associated with imatinib mesylate resistance in chronic myelogenous leukemia", Cancer Genet Cytogenet, 190, pp.46~48 (2009)